Inside Thundermist: How This FQHC Delivers Comprehensive, Community- Rooted Care
Written by Joshua Murdock, PharmD, BCBBS Thundermist Health Center doesn’t look like a typical health clinic. It feels like a small health system. In addition to its primary care services, this federally qualified health center (FQHC) offers substance usedisorder treatment, HIV care through the Ryan White HIV/AIDS Program, a dental practice, mobile medical units, and […]
Brian Litten on Making AssureCare Impossible to Ignore: An RXinsider Interview
By Joshua Murdock, PharmD, BCBBS AssureCare is an AI-powered population health management company whose platform spans payers, providers, and pharmacies; it’s built around whole-person care. The company recently brought in a new executive to help grow the platform’s reach. In August 2026, Brian Litten was named Executive Vice President (EVP) of Growth and Commercialization at […]
Natasha Baria Mehta Talks ACU-Serve’s Path to a Scalable Platform: An RXinsider Interview
Written by Joshua Murdock, PharmD, BCBBS ACU-Serve is a revenue cycle management company serving providers across post-acute care segments. Founded in 1993, the company has built its reputation on deep, specialized knowledge of a highly regulated niche. Natasha Baria Mehta was named President of ACU-Serve in May 2026, bringing more than 25 years of revenue […]
Meet Hal: How AI Automation Is Helping One Pharmacy Team Work Smarter, Not Harder
By Megan McCaskill, RPh, President of Compliance and Strategy at Horizon Pharmacy AI is quickly reshaping pharmacy operations. It can now help pharmacy teams work smarter by taking on repetitive, time-consuming tasks, freeing employees to focus on work that requires human judgment and meaningful communication. At Horizon Pharmacy, AI has moved from concept to practice […]
Nnamdi Njoku on Omnicell’s Next Chapter: An RXinsider Interview
Written by Joshua Murdock, PharmD, BCBBS Nnamdi Njoku was named President of Omnicell in July 2026, adding the title to his existing role as chief operating officer (COO). In this exclusive interview with RXinsider, Njoku discusses the priorities shaping Omnicell’s roadmap, including the OmniSphere cloud platform and Titan XT automated dispensing system, and how they […]
Reflection on the Impact of the Inflation Reduction Act (IRA) Negotiated Drug Pricing
Contributed by SME, Steven Miller, 340B Health The Inflation Reduction Act (IRA) continues to reshape the Medicare prescription drug landscape through the implementation of the Medicare Drug Price Negotiation Program. On January 1, 2026, negotiated Maximum Fair Prices (MFPs) took effect for the first 10 Medicare Part D drugs selected by the Centers for Medicare […]
Beyond Clinical Trials: Why Medical Affairs Matters in Compounding Pharmacy
Contributed by SME: Jean Cunningham, PharmD, BCPS, Senior Director of Medical Affairs, Empower Pharmacy In healthcare, randomized controlled trials remain the gold standard for evaluating safety and efficacy. Pharmacists and other healthcare professionals should continue to advocate for high-quality evidence whenever possible. However, those who work in compounding pharmacy face an often-overlooked reality. The evidence […]
The Execution Problem Inside 340B Compliance
Contributed by SME: Valerie Bandy, PharmD, MBA, Vice President, Pharmacy Solutions, Tecsys The 340B Drug Pricing program has been under a microscope lately. Senator Bill Cassidy’s proposals to tighten oversight have once again put the program’s future in question, and pharmaceutical manufacturers have begun withdrawing discounts from hospitals that don’t meet their own requirements. This […]
Mastering the Momentum: Why Cash Flow, Not Margin, Dictates Pharmacy Success
Contributed by SME, Mike Bollinger, Director of Pharmacy, Live Oak Bank The Delicate Balance: Inside Pharmacy Cash FlowThe cash flow of an independent pharmacy is clunky. To the untrained eye, it looks highly unpredictable and scary, but to someone who understands the flow of funds, it is incredibly telling.The daily operations of a pharmacy rely […]
Building a Modern Data Integrity Assessment Program for 503B Compounding Facilities
Contributed by SME: Diane K Gates, President, CenPharma 503B outsourcing facilities sit at a difficult intersection. They operate with the pace and variability of a hospital pharmacy, but they are held to CGMP expectations that increasingly resemble those applied to large commercial drug product manufacturers. Nowhere is this tension more visible than in data integrity. […]
